Oridonin inhibits inflammation of epithelial cells via dual-targeting of CD31 Keap1 to ameliorate acute lung injury

IntrodcutionAcute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are major causes of COVID-19 mortality. However, drug delivery to lung tissues is impeded by endothelial cell barriers, limiting the efficacy of existing treatments. A prompt and aggressive treatment strategy is there...

Повний опис

Бібліографічні деталі

Автори:	Yue Zhao, Hua Jin, Kawai Lei, Li-Ping Bai, Hudan Pan, Caiyan Wang, Xiaoming Zhu, Yanqing Tang, Zhengyang Guo, Jiye Cai, Ting Li
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2023-04-01
Серія:	Frontiers in Immunology
Предмети:	acute lung injury COVID-19 CD31 Keap1 oridonin nanoparticles
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1163397/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!